Studies have shown that the expression of TYRO3 is increased in immunotherapy-resistant tumor cells, and TYRO3 signaling pathway inhibits the ferroptosis of tumor cells by up-regulating the expression of SLC3A2 and other genes. Here, SLC3A2 is linked to neoplasm.